26
Jun
Chennai: The Defense Research and Development Organisation (DRDO) on Friday told the Madras High Court that 40 pharmaceutical companies have evinced interest in the anti-Covid-19 drug produced by it. The submission came in response to a Public Interest Litigation complaining that DRDO had given a license to Dr Reddy's Laboratories in Hyderabad for the production of the anti-Covid-19 drug. The premier scientific organisation said that it has invited Expressions of Interest (EoIs) to produce its D-glucose (2-DG) and adjunct drug to treat Covid patients, and already 40 pharmaceutical companies had expressed interest. Additional Solicitor General R. Sankaranarayanan told a bench of…